Fig. 1 · Structure
Documents & Downloads
Heptadecanoyl ethanolamide
Endogenous Cannabinoid
Heptadecanoyl ethanolamide is an endogenous cannabinoid that targets cannabinoid receptors in the body. As a synthetic analog of palmitoylethanolamide (PEA), it features a unique 17-carbon fatty acid chain, which may enhance its biological activity. This compound is primarily utilized in research exploring pain modulation, inflammation, and neuroprotection. Its potential applications also include studies on the endocannabinoid system and its role in various physiological processes.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 53832-59-0 |
| Applications | Endogenous Cannabinoid |
| Formula | C19H39NO2 |
| Molecular Weight | 313.52 |
| SMILES | O=C(CCCCCCCCCCCCCCCC)NCCO |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.